← Back to Clinical Trials
Recruiting NCT05687929
Real-World Registry Study on Clinical Analgesic Effect of Acetylaconitine Tablets
Trial Parameters
Condition Chronic Pain
Sponsor Ke Ma
Study Type OBSERVATIONAL
Phase N/A
Enrollment 3,500
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2023-03-27
Completion 2023-06-15
Brief Summary
1. To observe the clinical analgesic effect, safety and adverse reactions of acetylaconitine. 2. To study and analyze the main influencing factors of the acetylaconitine tablets.
Eligibility Criteria
Inclusion Criteria: * Patients with chronic pain \> 1 month and VAS \> 40 mm Patients who can take the acetylaconitine tablets orally Exclusion Criteria: * Patients who cannot communicate or receive follow-up Patients allergic to acetylaconitine Patients who have taken the acetylaconitine drugs orally